Clinical Trial Update: A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer [Phase 1]

View source ↗

Summary

An update on a Phase I gene therapy trial of FP253/Fludarabine for prostate cancer. The study is sponsored by Biotech Equity Partners Pty Ltd and is currently l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• FP253/Fludarabine

Snippet

Sponsor: Biotech Equity Partners Pty Ltd | Conditions: Prostate Cancer | Phase 1 | Status: UNKNOWN